SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012417
Filing Date
2018-05-09
Accepted
2018-05-09 16:16:34
Documents
70
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q svra-10q_20180331.htm 10-Q 1713433
2 EX-31.1 svra-ex311_8.htm EX-31.1 13895
3 EX-31.2 svra-ex312_7.htm EX-31.2 13882
4 EX-32.1 svra-ex321_9.htm EX-32.1 10683
  Complete submission text file 0001564590-18-012417.txt   6973822

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT svra-20180331.xml EX-101.INS 1542546
6 XBRL TAXONOMY EXTENSION SCHEMA svra-20180331.xsd EX-101.SCH 62793
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE svra-20180331_cal.xml EX-101.CAL 54912
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE svra-20180331_def.xml EX-101.DEF 178086
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20180331_lab.xml EX-101.LAB 436077
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20180331_pre.xml EX-101.PRE 328383
Mailing Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746
Business Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746 512-614-1848
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 18818475
SIC: 2834 Pharmaceutical Preparations